VJHemOnc Podcast

VJHemOnc Podcast

Por: VJHemOnc
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com
200 episodios disponibles

Latest episodes of the podcast VJHemOnc Podcast

Mostrando página 4 de 10

Global perspectives on blood cancers: addressing disparities in awareness, diagnosis, and treatment 09/09/2024
Insights into PV and ET: treating the AYA population, defining goals when treating patients, & more 02/09/2024
Hemophilia updates from ISTH 2024: ongoing clinical trials, emerging gene therapies & remaining challenges 19/08/2024
Inflammation and immune interventions in MDS: targeting STAT, IRAK4, & more 12/08/2024
Updates in the treatment of SCD and thalassemia from EHA 2024: key trial updates, challenges with gene therapies & unmet needs 05/08/2024
Unmet treatment needs in MF: managing prefibrotic disease & thrombocytopenia, novel agents & endpoints for clinical trials 29/07/2024
The role of BTK inhibitors in MCL, ongoing trials & future outlooks: updates from EHA 2024 22/07/2024
Novel developments in lower-risk MDS & important practical considerations when treating patients 15/07/2024
Updates on the use of BCMA-targeting bispecific antibodies in R/R multiple myeloma: insights from EHA & ASCO 2024 08/07/2024
Updates in the treatment of CLL from EHA 2024: BTK and BCL2 inhibitor combinations, BTK degraders, and more 01/07/2024
Highlights from ISA 2024: the importance of early diagnosis in AL amyloidosis, trials in progress & patient selection for SCT 25/06/2024
Treating LR-MDS beyond ESA failure: currently approved agents, novel approaches & future outlooks 11/06/2024
BPDCN treatment and management: CD123-targeting agents, CNS involvement & approaching pediatric/AYA patients 03/06/2024
The future of CAR-T therapy in lymphoma, addressing the risk of secondary malignancy & the optimal sequencing of these agents with bispecific antibodies 16/05/2024
iwMyeloma 2024 Session I: approaching bone disease, clinical trial updates & the value of MRD as an endpoint in trials 10/05/2024
Managing anemia in MF, key emerging trials in the UK, and approaching young patients with MPNs 03/05/2024
Highlights from EBMT 2024: treating & managing GvHD & understanding the role of the gut microbiome 26/04/2024
The importance of cardio-oncology: awareness around the ESC 2022 guidelines & the value of building MDTs 11/04/2024
Exploring the possibility of early interception in smoldering myeloma: novel agents, challenges & advances in risk stratification 04/04/2024
CHIP & CCUS: knowledge gaps, ongoing trials & recommendations for approaching patients with myeloid precursors 28/03/2024
« Primera ‹ Anterior 1 2 3 4 5 6 ... 10 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA